Endometriosis. Endometriosis, unspecified
Conditions
Interventions
Intervention 1: Intervention group: On the third day of menstruation, all participants will be evaluated with TVS for measuring endometrial thickness and antral follicle counts. Then, the GnRH agonist
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Women with 18 to 35 year-old Body mass index lower than 30 kg/m2 In her first IVF cycle Without any uterine diseases Sperm motility of at least 20% in sperm analysis Anti-mullerin hormone greater than 1 ng/ml
Exclusion criteria
Exclusion criteria: Women who underwent letrozole or clomiphene therapy for induction ovulation Sever endometriosis with DIE Submucosal myoma with any size and intramural myoma greater than 3 cm was detected in transvaginal ultrasound Withdraw to participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The total prescribed dosage of Cinnal-f, and HMG. Timepoint: Once, at the trigger day. Method of measurement: Will be calculated by gynecologic.;The estradiol level. Timepoint: Once, at the trigger day. Method of measurement: Blood sample.;The oocyte number, and quality. Timepoint: Once, at puncture day. Method of measurement: According to the oocyte puberty degree, the oocyte quality will be determined.;The embryo quality. Timepoint: Once, after in vitro fertilization. Method of measurement: According to Gardner system. | — |
Secondary
| Measure | Time frame |
|---|---|
| Biochemical pregnancy. Timepoint: Once, 14 days after fetus transfer. Method of measurement: Blood sampling.;Clinical pregnancy. Timepoint: Once, 6 to 8 weeks after fetus transfer. Method of measurement: Pregnancy sac observation in transvaginal ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamideh Pakniat
Tehran University of Medical Sciences
Outcome results
None listed